Group 1 - The 2025 Liaocheng Drug Safety Publicity Week was officially launched from September 1 to 7, with a focus on ensuring public health and safety [1] - The city government emphasized the implementation of precise law enforcement to address prominent issues and high-frequency risks identified during regulatory processes [1] - A comprehensive inspection of drug operating and usage units was conducted, utilizing the national drug traceability system to ensure traceability and accountability [1] Group 2 - A collaborative enforcement mechanism was established among various departments, including market regulation, health, and medical insurance, to enhance inspection efficiency [2] - The "law enforcement + service" model was innovated to support key industrial chains, particularly in biomedicine, through on-site visits and problem-solving reports [2] - A post-supervision service mechanism was implemented to assist enterprises in addressing issues and improving management practices [2]

Group 1 - The 2025 Liaocheng Drug Safety Publicity Week was officially launched from September 1 to 7, with a focus on ensuring public health and safety [1] - The market supervision department is implementing precise law enforcement by addressing prominent issues raised by the public and conducting targeted enforcement actions to maximize effectiveness [1] - A comprehensive inspection of drug operating units is being conducted using the national drug traceability system to ensure traceability and accountability of vaccines and special drugs [1] Group 2 - A collaborative enforcement mechanism has been established among various departments, including market supervision, health, and medical insurance, to enhance efficiency and reduce the burden on enterprises [2] - The "law enforcement + service" model is being innovated to support key industrial chains, particularly in biomedicine, through on-site visits and comprehensive assistance [2] - A post-supervision service mechanism has been established to help enterprises analyze issues and improve management through joint follow-up visits by various regulatory personnel [2]